Market Cap 472.05B
Revenue (ttm) 88.82B
Net Income (ttm) 14.07B
EPS (ttm) N/A
PE Ratio 18.81
Forward PE 17.97
Profit Margin 15.84%
Debt to Equity Ratio 0.50
Volume 8,824,800
Avg Vol 8,294,124
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 90%
Beta 0.38
Analysts Strong Sell
Price Target $203.50

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
LiquidThetaOptions
LiquidThetaOptions Nov. 16 at 2:39 AM
💎 LiquidTheta® Live Actionable Trade Asset: $JNJ Contracts: $JNJ December 18, 2026 $200 Calls Scale in: $13.38- $16.36 Scale out: $52.05-$89.22 Profit Potential : 71% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 15 at 10:50 PM
Hedge Alert Live - Protect Your Portfolio Contract: $JNJ $195.00 Put · NOV 21, 2025 Exp Entry Price: $1.33 - $1.44 Exit Price Target: $3.03 Profit Margin: +128% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
WayneSmith
WayneSmith Nov. 15 at 10:46 PM
$XOM $JNJ $PLTR $BABA The bulls have taken ful control of the market.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 9:55 PM
$JNJ Trade Plan: Market Context: The last close at $195.93 is near the 60D high of $197.18, indicating a potential resistance level. The RSI of 63.32 suggests the stock is nearing overbought territory, which may limit upside potential in the short term. Directional Bias: The stock shows bullish momentum as it is above both the 30-day moving average (MA30) of $190.35 and the 50-day moving average (MA50) of $185.84. However, the high RSI indicates caution, as it may lead to a pullback. Suggested Entry: Consider entering a long position if the price breaks above $197.18, confirming upward momentum. Stop: Set a stop loss at $192.00 to manage risk. Targets: First target at $200.00, aligning with psychological resistance. Second target at $205.00, based on potential continuation of bullish sentiment. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Jason_
Jason_ Nov. 15 at 7:25 PM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 15 at 10:30 AM
Enter: $JNJ Calls Strike Price: $200 Expiry Date: DEC 05 2025 Buy in Price: $1.20 - $1.40 Sell Price: $2.21 Profit : +84% (Turn every $1 into $1.84) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 7:53 AM
$JNJ Trade Plan: Market Context: The last close at $195.93 is near the 60D high of $197.18, indicating a potential resistance level. The RSI of 63.32 suggests the stock is nearing overbought territory, which may limit upside potential in the short term. Directional Bias: The stock shows bullish momentum as it is above both the 30-day moving average (MA30) of $190.35 and the 50-day moving average (MA50) of $185.84. However, the high RSI indicates caution, as it may lead to a pullback. Suggested Entry: Consider entering a long position if the price breaks above $197.18, confirming upward momentum. Stop: Set a stop loss at $192.00 to manage risk. Targets: First target at $200.00, aligning with psychological resistance. Second target at $205.00, based on potential continuation of bullish sentiment. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
MichaelKTrades
MichaelKTrades Nov. 15 at 7:25 AM
Drug manufacturers in their own secular bull market. Patiently waiting for pullbacks/ new bases to form $LLY $GSK $AZN $JNJ
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:14 PM
$JNJ: The market context shows a recent close at $195.93, with an RSI of 63.32 indicating bullish momentum but approaching overbought territory. The current price is above both the 30-day MA of $190.35 and the 50-day MA of $185.84, suggesting a strong upward trend. The 60-day high of $197.18 provides a potential resistance level, while the low of $173.33 establishes a solid support range. Directional bias is bullish, supported by the price action above key moving averages and the recent high. Suggested entry: $196.00, slightly above the last close to confirm upward momentum. Stop loss: $193.00, below the 30-day MA to minimize risk. Targets: $198.00 (near the 60D high) and $200.00 (psychological resistance). Monitor RSI closely for signs of reversal as it approaches overbought levels. https://privateprofiteers.com
0 · Reply
DEXWireNews
DEXWireNews Nov. 14 at 9:27 PM
Johnson & Johnson ( $JNJ) Finds Support at Key Level $JNJ broke out of its multiyear downtrend channel, supported by strong pharma growth, med-tech recovery, and easing legal risks🔥 YouTube: https://youtube.com/@DEXWireNews Instagram: https://instagram.com/DEXWireNews #JNJ #StockMarket
1 · Reply
Latest News on JNJ
Johnson & Johnson: Dividends Don't Lie

Nov 7, 2025, 5:40 AM EST - 8 days ago

Johnson & Johnson: Dividends Don't Lie


Cramer's Mad Dash: Johnson & Johnson

Nov 6, 2025, 9:54 AM EST - 9 days ago

Cramer's Mad Dash: Johnson & Johnson


Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 14 days ago

Best Dividend Aristocrats For November 2025

ABBV ABT ADM ADP AMCR AOS ATO


Best Dividend Kings: October 2025

Oct 29, 2025, 5:11 AM EDT - 17 days ago

Best Dividend Kings: October 2025

ABBV ABM ABT ADM ADP AWR BDX


J&J Stock Can Fall

Oct 28, 2025, 9:25 AM EDT - 18 days ago

J&J Stock Can Fall


Johnson & Johnson Stock To $134?

Oct 22, 2025, 2:00 PM EDT - 24 days ago

Johnson & Johnson Stock To $134?


Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript

Oct 14, 2025, 12:36 PM EDT - 4 weeks ago

Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript


J&J to spin off orthopedics business, raises full-year forecast

Oct 14, 2025, 6:26 AM EDT - 4 weeks ago

J&J to spin off orthopedics business, raises full-year forecast


LiquidThetaOptions
LiquidThetaOptions Nov. 16 at 2:39 AM
💎 LiquidTheta® Live Actionable Trade Asset: $JNJ Contracts: $JNJ December 18, 2026 $200 Calls Scale in: $13.38- $16.36 Scale out: $52.05-$89.22 Profit Potential : 71% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 15 at 10:50 PM
Hedge Alert Live - Protect Your Portfolio Contract: $JNJ $195.00 Put · NOV 21, 2025 Exp Entry Price: $1.33 - $1.44 Exit Price Target: $3.03 Profit Margin: +128% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
WayneSmith
WayneSmith Nov. 15 at 10:46 PM
$XOM $JNJ $PLTR $BABA The bulls have taken ful control of the market.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 9:55 PM
$JNJ Trade Plan: Market Context: The last close at $195.93 is near the 60D high of $197.18, indicating a potential resistance level. The RSI of 63.32 suggests the stock is nearing overbought territory, which may limit upside potential in the short term. Directional Bias: The stock shows bullish momentum as it is above both the 30-day moving average (MA30) of $190.35 and the 50-day moving average (MA50) of $185.84. However, the high RSI indicates caution, as it may lead to a pullback. Suggested Entry: Consider entering a long position if the price breaks above $197.18, confirming upward momentum. Stop: Set a stop loss at $192.00 to manage risk. Targets: First target at $200.00, aligning with psychological resistance. Second target at $205.00, based on potential continuation of bullish sentiment. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Jason_
Jason_ Nov. 15 at 7:25 PM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 15 at 10:30 AM
Enter: $JNJ Calls Strike Price: $200 Expiry Date: DEC 05 2025 Buy in Price: $1.20 - $1.40 Sell Price: $2.21 Profit : +84% (Turn every $1 into $1.84) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 7:53 AM
$JNJ Trade Plan: Market Context: The last close at $195.93 is near the 60D high of $197.18, indicating a potential resistance level. The RSI of 63.32 suggests the stock is nearing overbought territory, which may limit upside potential in the short term. Directional Bias: The stock shows bullish momentum as it is above both the 30-day moving average (MA30) of $190.35 and the 50-day moving average (MA50) of $185.84. However, the high RSI indicates caution, as it may lead to a pullback. Suggested Entry: Consider entering a long position if the price breaks above $197.18, confirming upward momentum. Stop: Set a stop loss at $192.00 to manage risk. Targets: First target at $200.00, aligning with psychological resistance. Second target at $205.00, based on potential continuation of bullish sentiment. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
MichaelKTrades
MichaelKTrades Nov. 15 at 7:25 AM
Drug manufacturers in their own secular bull market. Patiently waiting for pullbacks/ new bases to form $LLY $GSK $AZN $JNJ
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:14 PM
$JNJ: The market context shows a recent close at $195.93, with an RSI of 63.32 indicating bullish momentum but approaching overbought territory. The current price is above both the 30-day MA of $190.35 and the 50-day MA of $185.84, suggesting a strong upward trend. The 60-day high of $197.18 provides a potential resistance level, while the low of $173.33 establishes a solid support range. Directional bias is bullish, supported by the price action above key moving averages and the recent high. Suggested entry: $196.00, slightly above the last close to confirm upward momentum. Stop loss: $193.00, below the 30-day MA to minimize risk. Targets: $198.00 (near the 60D high) and $200.00 (psychological resistance). Monitor RSI closely for signs of reversal as it approaches overbought levels. https://privateprofiteers.com
0 · Reply
DEXWireNews
DEXWireNews Nov. 14 at 9:27 PM
Johnson & Johnson ( $JNJ) Finds Support at Key Level $JNJ broke out of its multiyear downtrend channel, supported by strong pharma growth, med-tech recovery, and easing legal risks🔥 YouTube: https://youtube.com/@DEXWireNews Instagram: https://instagram.com/DEXWireNews #JNJ #StockMarket
1 · Reply
GettnFibbywIT
GettnFibbywIT Nov. 14 at 7:35 PM
$JNJ $XLV $SPY $XHP.X JNJ/ Weekly - And what a week it.s been, so far:
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:33 PM
Hedge Alert Live - Protect Your Portfolio Contract: $JNJ $195.00 Put · NOV 21, 2025 Exp Entry Price: $1.73 - $1.77 Exit Price Target: $3.86 Profit Margin: +123% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
ewforecast
ewforecast Nov. 14 at 3:38 PM
$JNJ Johnson & Johnson: Extended Wave 3 Nearing Completion, Watching #stocks #equity #JohnsonAndJohnson #bullish #impulse #technical #analysis #elliottwave #freechart 👇👇 https://wavetraders.com/free-charts/johnson-n-johnson-extended-wave-3-nearing-completion-nov-14-2025/
0 · Reply
BarkingPuppy
BarkingPuppy Nov. 14 at 3:21 PM
$ELTP $ABBV $LLY $JNJ $MRK Someone is looking to make a deal..........Rumors are everywhere!!!!!!! News next week?????? AbbVie Inc.: Recently submitted a New Drug Application (NDA) for tavapadon, a novel treatment for Parkinson's disease. Specific partners and agreements Glenmark Pharmaceuticals: Elite has a license, manufacturing, and supply agreement with Glenmark to market two of Elite's generic products in the US. Glenmark handles sales and distribution, while Elite receives manufacturing and license fees. TAGI Pharma, Epic Pharma, and Valeant Pharmaceuticals International: Elite has licensed generic and OTC products to these companies. Ascend Laboratories: Elite provides contract manufacturing for this subsidiary of Alkem Laboratories Ltd..
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 14 at 1:41 PM
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 14 at 1:28 PM
BMY Stock Slumps 5% After It Scraps Heart Drug Study $BMY $DUHP $JNJ https://stocktwits.com/news/equity/markets/bmy-stock-slumps-after-it-scraps-heart-drug-study/cLPQOJeRE4Q
0 · Reply
notreload_ai
notreload_ai Nov. 14 at 1:21 PM
$BMY and $JNJ have stopped a major Phase 3 trial of milvexian for acute coronary syndrome after an interim review showed the drug is unlikely to meet its main goals. Other trials continue with results expected in 2026. https://notreload.xyz/bristol-myers-jnj-halt-milvexian-heart-drug-trial/
0 · Reply
Suite510
Suite510 Nov. 14 at 12:24 PM
$JNJ $KVUE $SPX Bellwether’ Trial Over Johnson & Johnson’s Baby Powder Opens in Los Angeles About to get reckt, 😃 like another 966M verdict 😂
0 · Reply
_Verticality
_Verticality Nov. 14 at 10:32 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $TSN $JNJ $VTR $CB b
0 · Reply
_Verticality
_Verticality Nov. 14 at 9:22 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $AI $JNJ $LITE $SHOP o
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:53 AM
Hedge Alert Live - Protect Your Portfolio Contract: $JNJ $195.00 Put · NOV 21, 2025 Exp Entry Price: $1.92 - $1.93 Exit Price Target: $3.86 Profit Margin: +100% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 2:48 AM
$JNJ is currently trading at $195.25, showing a strong upward momentum with an RSI of 61.8, indicating it is approaching overbought territory but still has room for further gains. The price is above both the 30-day moving average (MA30) of $190.1 and the 50-day moving average (MA50) of $185.49, suggesting a bullish trend. Given the recent 60-day high of $196.0, a breakout above this level could signal further upward movement. The 60-day low of $173.33 provides a clear support level. Suggested trade plan: - Entry: $196.10 (breakout above the 60D high) - Stop: $193.00 (below recent support) - Target 1: $200.00 (psychological level) - Target 2: $205.00 (next resistance level) This plan leverages the current bullish trend while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply